Home
CRSP
CRSP News

Latest CRISPR Therapeutics AG (CRSP) News on January 19, 2025

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential

Insider Monkey

2 days ago

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?

Zacks

2 days ago

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Motley Fool

3 days ago

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

My 10 Top Stocks to Buy to Start the New Year Off Right

Motley Fool

3 days ago

My 10 Top Stocks to Buy to Start the New Year Off Right

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

4 days ago

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts

Motley Fool

5 days ago

Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones

GlobeNewswire

6 days ago

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones

3 Mid-Cap Stocks That Could Take Off in 2025

Motley Fool

10 days ago

3 Mid-Cap Stocks That Could Take Off in 2025

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

11 days ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

11 days ago

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

MT Newswires

12 days ago

BofA Securities Adjusts Price Target on CRISPR Therapeutics to $85 From $98, Maintains Buy Rating

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

GlobeNewswire

12 days ago

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

Vertex, startup Orna to partner on gene editing research

BioPharma Dive

12 days ago

Vertex, startup Orna to partner on gene editing research

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Zacks

18 days ago

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In?

Insider Monkey

19 days ago

Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In?

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey

21 days ago

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Zacks

23 days ago

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Institutional investors may adopt severe steps after CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 8.3% drop adds to a year losses

Simply Wall St.

25 days ago

Institutional investors may adopt severe steps after CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 8.3% drop adds to a year losses

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

Zacks

a month ago

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

Motley Fool

a month ago

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

1 big new Green Flag for CRISPR Therapeutics' Stock

Motley Fool

a month ago

1 big new Green Flag for CRISPR Therapeutics' Stock

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

Zacks

a month ago

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

Motley Fool

a month ago

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

3 Things You Need to Know if You Buy CRISPR Therapeutics Today

Motley Fool

a month ago

3 Things You Need to Know if You Buy CRISPR Therapeutics Today

Editas to lay off staff after search for sickle cell partner comes up empty

BioPharma Dive

a month ago

Editas to lay off staff after search for sickle cell partner comes up empty

Is CRISPR Therapeutics AG (CRSP) the Worst ARK Stock to Buy According to Short Sellers?

Insider Monkey

a month ago

Is CRISPR Therapeutics AG (CRSP) the Worst ARK Stock to Buy According to Short Sellers?

MT Newswires

a month ago

CRISPR Therapeutics Says Trial Data Show CTX112 Has 'Potential' to Treat Malignancies

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

a month ago

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

2 Biotech Stocks to Buy Hand Over Fist in December

Motley Fool

a month ago

2 Biotech Stocks to Buy Hand Over Fist in December

CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a month ago

CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock?

Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?

Zacks

a month ago

Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?

3 of the Best Growth Stocks You Can Buy for Less than $100

Motley Fool

a month ago

3 of the Best Growth Stocks You Can Buy for Less than $100

Wall Street Analysts Think CRISPR Therapeutics (CRSP) Could Surge 58.3%: Read This Before Placing a Bet

Zacks

2 months ago

Wall Street Analysts Think CRISPR Therapeutics (CRSP) Could Surge 58.3%: Read This Before Placing a Bet

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

Motley Fool

2 months ago

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

Motley Fool

2 months ago

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

3 Monster Stocks in the Making

Motley Fool

2 months ago

3 Monster Stocks in the Making

Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024?

Insider Monkey

2 months ago

Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024?

CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?

Zacks

2 months ago

CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?

CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now

CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest

BioPharma Dive

2 months ago

CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest

CRISPR Therapeutics AG (CRSP): Among ARK Invest’s Top Stock Picks for 2024

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP): Among ARK Invest’s Top Stock Picks for 2024

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

Motley Fool

2 months ago

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

Where Will CRISPR Therapeutics Be in 3 Years?

Motley Fool

2 months ago

Where Will CRISPR Therapeutics Be in 3 Years?

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire

2 months ago

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029

Motley Fool

2 months ago

3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029

Elon Musk will be 'vitally important' in Trump admin: Cathie Wood

Yahoo Finance Video

2 months ago

Elon Musk will be 'vitally important' in Trump admin: Cathie Wood

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

2 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

GlobeNewswire

2 months ago

CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

2 months ago

CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Morningstar Research

2 months ago

Analyst Report: CRISPR Therapeutics AG

Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

Zacks

2 months ago

Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates

Zacks

2 months ago

CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates

CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates

MT Newswires

2 months ago

CRISPR Therapeutics' Q3 Net Loss Narrows

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire

2 months ago

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

3 Companies Building Tomorrow's Game-Changing Technologies

Motley Fool

2 months ago

3 Companies Building Tomorrow's Game-Changing Technologies

CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average

CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average

Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers

Motley Fool

3 months ago

Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers

Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock?

Insider Monkey

3 months ago

Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock?

CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store?

Zacks

3 months ago

CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store?

The Ultimate Biotech Stock to Buy With $50 Right Now

Motley Fool

3 months ago

The Ultimate Biotech Stock to Buy With $50 Right Now

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

Zacks

3 months ago

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

Zacks

3 months ago

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

3 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

Zacks

3 months ago

Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

We Think CRISPR Therapeutics (NASDAQ:CRSP) Can Easily Afford To Drive Business Growth

Simply Wall St.

3 months ago

We Think CRISPR Therapeutics (NASDAQ:CRSP) Can Easily Afford To Drive Business Growth

3 Bargain Stocks to Buy in a Market That's Priced for Perfection

Motley Fool

3 months ago

3 Bargain Stocks to Buy in a Market That's Priced for Perfection

Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds?

Insider Monkey

3 months ago

Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds?

Why I Keep Buying These 14 Incredible Growth Stocks

Motley Fool

3 months ago

Why I Keep Buying These 14 Incredible Growth Stocks

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Is CRISPR Therapeutics Stock a Buy?

Motley Fool

3 months ago

Is CRISPR Therapeutics Stock a Buy?

2 Biotech Stocks That Are Screaming Buys This Month

Motley Fool

3 months ago

2 Biotech Stocks That Are Screaming Buys This Month

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why

This Healthcare Growth Stock Could Be a Steal of a Deal Right Now

Motley Fool

3 months ago

This Healthcare Growth Stock Could Be a Steal of a Deal Right Now

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m

Pharmaceutical Technology

3 months ago

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m

MT Newswires

3 months ago

RBC Cuts Price Target on CRISPR Therapeutics to $53 From $60, Keeps Sector Perform Rating

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

Zacks

4 months ago

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now

Quartz

4 months ago

Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now

These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer

Motley Fool

4 months ago

These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know

CRISPR Therapeutics (NASDAQ:CRSP) shareholders have endured a 59% loss from investing in the stock three years ago

Simply Wall St.

4 months ago

CRISPR Therapeutics (NASDAQ:CRSP) shareholders have endured a 59% loss from investing in the stock three years ago

3 Dirt Cheap Stocks to Buy Right Now

Motley Fool

4 months ago

3 Dirt Cheap Stocks to Buy Right Now

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?

Motley Fool

4 months ago

Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know

1 Biotech Stock Down 62% to Buy and Hold

Motley Fool

4 months ago

1 Biotech Stock Down 62% to Buy and Hold

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Motley Fool

4 months ago

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why

CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers

Insider Monkey

4 months ago

CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers

Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?

Motley Fool

4 months ago

Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?

Why Is CRISPR Therapeutics (CRSP) Down 7.7% Since Last Earnings Report?

Zacks

4 months ago

Why Is CRISPR Therapeutics (CRSP) Down 7.7% Since Last Earnings Report?

3 Monster Biotech Stocks to Buy Before 2025

Motley Fool

5 months ago

3 Monster Biotech Stocks to Buy Before 2025

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

Motley Fool

5 months ago

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

CRISPR (CRSP) Loses 24% YTD: How Should You Play the Stock?

Zacks

5 months ago

CRISPR (CRSP) Loses 24% YTD: How Should You Play the Stock?

MT Newswires

5 months ago

Truist Adjusts Price Target on CRISPR Therapeutics to $100 From $120, Maintains Buy Rating

Got the Market Sell-Off Blues? Do These 3 Things Right Now

Motley Fool

5 months ago

Got the Market Sell-Off Blues? Do These 3 Things Right Now

Morningstar Research

5 months ago

Analyst Report: CRISPR Therapeutics AG

Share on Social Networks: